PharmacoLearnIt’s Important to Know!

Global Health News

A weekly room for the health news that matters beyond India: the top pharmaceutical, medical and healthcare stories from around the world, plus top fives from South Asia, Europe, North America and Africa. Every story is verified on its original source page, and nothing here covers politics or finance. New editions land weekly; the October 2026 archive below is the launch set.

Regions

South Asia

Pharma and health news from India, Pakistan, Bangladesh, Nepal, Sri Lanka and the wider South Asian region, from immunisation campaigns and tuberculosis programmes to new medicine approvals.

Europe

Regulatory decisions, trials and outbreak reports from Europe, led by the EMA, MHRA and ECDC.

North America

FDA approvals, recalls, guidance and public health reports from the United States and Canada.

Africa

Outbreak response, immunisation and health system news from across Africa, from Africa CDC, WHO AFRO and national programmes.

All editions

Flat illustration of a teal globe beside a gold vaccine vial and a gold shield on navy.

Week ending 25 October 2026: WHO reports Bundibugyo outbreak expansion and launch of TUMAINI vaccine trial

25 stories

Flat illustration of a teal globe beside a generic laboratory flask and a gold shield on navy.

Week ending 18 October 2026: DRC Ebola outbreak becomes the second largest on record

23 stories

Flat illustration of a teal globe beside rising teal and gold bar-chart columns and a gold medical cross on navy.

Week ending 11 October 2026: WHO launches global guidelines on obesity in children and adolescents

17 stories

Flat illustration of a white aircraft silhouette over a teal globe on a navy starry background, with a small gold medical cross badge.

Week ending 4 October 2026: MSF staff member with Bundibugyo virus disease medically evacuated from DR Congo to the Netherlands

16 stories

Also: the Global Pharma News August 2026 retrospective.

Every story on this page was verified on its original source page. Coverage is pharma, medical, healthcare and community health only; no politics or finance.